Proof of Market of an Innovative Microbial Air Sampler Hybrid (MASH)

微生物空气污染的测量对于制药、医疗保健和食品等行业至关重要，以确保符合立法标准。有几个案例研究表明，目前的采样器失败了，成本高达百万英镑，例如辉瑞工厂因无菌工艺未优化以降低微生物污染风险而被禁止向欧盟供应药物;凯龙未能监测微生物污染导致4800万流感疫苗受到污染（和撤回）-美国需求的一半。我们已经确定了一个机会，开发一种创新的采样器，使用更小的琼脂板，能够在10分钟内以高效率采样1立方米。该PoM的目的是确认市场需求，细分和技术发展路径。到2019年，全球空气监测市场预计将达到61.6亿美元，我们的早期预测是0.3%的市场渗透率，相当于开发后第3年的收入为1850万美元（1390万英镑）。

The measurement of microbial air contamination is essential in sectors such as pharmaceuticals, healthcare & food to ensure legislative standards are met. There are several case studies where current samplers have failed costing £M's e.g. Pfizer plant banned from supplying drugs to EU due to aseptic processes not optimised to reduce risk of microbial contamination; Chiron’s failure to monitor microbial contamination led a contamination (and withdrawal) of 48M flu vaccines – half of U.S. demand. We have identified an opportunity to develop an innovative sampler using the smaller agar plate, capable of sampling 1m3 in 10 minutes at high efficiency. The purpose of this PoM is to confirm the market appetite, segmentation and technology development path. The global market for air monitoring is expected to reach $6.16bn, by 2019, and our early projections are 0.3% of market penetration, equating to revenues of $18.5M (£13.9m) by year-3 post development.